It has been demonstrated that the effect of a drug, chemical, or poison is diurnal phase dependent. The circadian variation in drug response could be attributed to the diurnal fluctuations of several factors, including absorption, distribution, metabolism, and excretion. Another important factor in determining the response to CNS drugs is the circadian rhythm of brain sensitivity to drugs. The diurnal variability in the concentration of brain neuromodulators could in part explain the circadian rhythm of brain sensitivity. The present paper focuses on the interrelationships between the levels of neuromodulators and the chronopharmacology and chronotoxicology of CNS drugs. Evidence is presented to show that the circadian rhythm of specific brain neuromodulators plays an important role in the pharmacologic or toxicologic action of amphetamine, barbiturates, morphine, and ethanol.
CIRCADIAN LDso RHYTHMS OF DL-AMPHETAMINES
Twenty-four hour LDSo rhythms for &amphetamines were determined in isolated and aggregated mice (Walker, 1972) . In all cases, &amphetamine was most toxic during the dark phase of the 24-hr light-dark cycle (on 8:00 hr, off 20:00 hr ( Table 1) . Amphetamine depletes norepinephrine stores, in addition to acting directly. The relationship between amphetamine and endogenous catecholamine levels is reflected in these results. Several investigators have reported circadian rhythms in the brain for concentrations of norepinephrine (Friedman and Walker, 1%8, 1%9 ; Manshardt and Wartman, 1%8), tyrosine hydroxylase activity (McGeer and McGeer. 1966) . and for norepinephrine storage vesicles (Walker et al., 1971) . The caudate nucleus and midbrain norepinephrine levels were found to reach their peak during the dark phase of the illumination cycle. These levels are significantly different from those found during the light phase ( Table 2) in the ability of reserpine to deplete norpinephrine. These authors suggested a more rapid turnover rate for brain norepinephrine during the dark period than during the light period. These studies indicate that the storage and synthesis of catecholamines in brain tissue of rodents is augmented during the dark period. Thus the 24-hr toxicity rhythm of amphetamine is most probably related to the endogenous brain catecholamine pattern.
CHRONOTOXICITY OF BARBITURATES
Twenty-four-hour LDH, values for secobarbital, hexobarbital, and pentobarbital were determined in male Swiss-Webster mice (Sermons el al., 1980) . Results obtained in this study revealed that the toxicity of these various barbiturates was influenced by the 24 hr light/dark cycle. The barbiturates tested were found to be significantly more toxic during the dark phase (O600 hr) of the illumination cycle and least toxic during the light phase (1200 hr) ( Figs. 1.2.3) . Several investigators have shown that there is a fluctuation in the levels of centrally acting depressants when monitored for periods of 24 hr (Bianchine and Ferguson. 1967; Friedman and Walker, 1969; Jori el al., 1970) . Nelson and Halberg (1973) observed higher brain concentration of pentobarbital when mice were injected in the dark phase rather than the light phase of the 24 hr light/dark cycle. In a related study, Holcslaw et al. (Holcsiaw el a/., 1975) observed that mice maintained under the standard alternating light/dark cycle exhibited circadian rhythms in hexobarbital brain concentration. Hexobarbital concentration was significantly higher in the dark phase as compared with the light phase. Vessel (1968) suggested that the duration of sleep or the degree of toxicity of barbiturates is determined by the rate of drug elimination from the brain of animals. In the case of barbiturates, this rate is determined in part by the speed at which these compounds are metabolized and excreted by the liver. It is expected that the slower the rate of metabolism, the higher the toxicity of the drug. Other investigators have reported a correlation between barbiturate toxicity and the rate of barbiturate oxidation by the liver microsomal enzyme system (Cooper and Brodie, 1955; Radzialowski and Bousquet, 1968; Nair and Caspar, 1969; Muller, 1971; Joannides and Parks, 1975) . These authors further reported that barbiturate metabolizing enzyme activity was highest in the dark phase and lowest during the light phase. The implication is that barbiturate toxicity would be greatest in the light phase when its metabolizing enzyme activity is at minimum. However, no correlation was observed between these findings and our studies (Sermons et al., 1980) . This lack of correlation with our results could be due to the possibility that barbiturates toxicity is nut solely dependent upon metabolism. As in the case of amphetamine toxicity (Walker, 1972) , the circadian pattern of barbiturates LDso could be related to the levels of endogenous brain catecholamines. but 180" out of phase with midbrain norepinephrine level and caudate nucleus histamine levels. These findings suggest that endogenous biological rhythms of certain specific biogenic amines may be important factors influencing the toxicity of CNS drugs.
CIRCADIAN RHYTHMS OF BRAIN ENDORPHINS, MORPHINE ANALGESIA, AND PAIN SENSITIVITY
A circadian rhythm for pain sensitivity and morphine analgesia has been demonstrated in mammals and man. Lutsch and Morris (1972) presented evidence to show that morphine sulfate displays quantitative variations in degree of analgesia produced over a 24-hr period, characterized by a peak analgesia during the dark phase and a trough during the light phase. Reversal of the lighting regimen inverts this pattern, and in constant light there is no significant change in morphine's analgesic activ-it^.^ These results suggest a photoperiodic effect.
Frederickson and co-workers (1977) observed a diurnal rhythm in the responsiveness of mice to nociceptive stimuli and in the hyperalgesic activity of naloxone.
In a preliminary report, some correlation between the activity of the endogenous opioid system and the ability of mice to withstand noxious stimuli has been demonstrated (Weshe and Frederickson, 1979 ). An increase in whole mouse brain total opioid levels, determined by mouse vas deferens bioassay, was observed in mice sacrificed in the late afternoon.
Diurnal variations in opiate receptor binding in rat brain have recently been reported (Naber et ul., 1981) . Scatchard analysis indicated that the differences in binding throughout the day were not due to changes in affinity but to changes in the number of binding sites. Maximal binding was found in the first half of the dark phase, which is the active phase in nocturnal rodents (Naber et al., 1981) . The existence of a marked circadian rhythm in opiate-receptor binding is of both physiological and methodological relevance since studies investigating the effects of drug on opiate receptor should consider that physiological changes in receptor number occurs over a few hours.
Studies aimed at determining circadian variations in sensory detection and pain thresholds during morning versus early evening hours in human subjects revealed diurnal variations in pain thresholds (Rogers and Vilkin, 1978) . Pain thresholds were significantly higher in the early morning than they were in the early evening. Naloxone decreased diurnal variations in pain sensitivity and somatosensory-evoked potentials in a group of 35 subjects (Davis et al., 1978) . 3Data for free-running individuals in constant illumination were not available. 
100-
The above-mentioned observations point to the possibility that endogenous opioid levels at least partially mediate diurnal variations in pain appreciation. To further expand on this possibility, the circadian pattern for 0-endorphin content of various regions of the rat brain was determined in our laboratory. 0-endorphin content of the hypothalamus, thalamus, and periaqueductal gray (PAC) rostra1 pons was measured by radioimmunoassay. Results obtained clearly demonstrate a circadian rhythm for &endorphin content in all brain regions studied (Figs. 4, 5 , 6 ; Table 3 ). The total immunoreactivity of the sample is a measure of both @-endorphin and 0-lipotropin (0-LPH) content. 0-endorphin immunoreactivity was directly assayed in samples in which the 0-LPH was separated prior to addition of the antiserum. Over a 24-hr period, total immunoreactivity in the hypothalamus increased during the dark phase and decreased during the l i t phase. A peak was observed at O400 hr (Fig. 4) . A significant (p c 0.001) sharp decline in the level of total immunoreactivity occurred at the onset of the light phase (0800 hr). As compared with changes observed in the hypothalamus, immunoreactivity in the thalamus varied to a much lesser extent. However, a peak was observed (p < 0.05) at O400 hr (Fig. 5) . In the PAG-rostra1 pons, a peak was observed at O400 hr and a nadir was seen at the onset of the dark phase (2000 hr) (Fig. 6 ). Significant changes in 0-endorphin content was still observed after separating @-LPH from the samples in the hypothalamus, thalamus and PAG-rostral pons (Table 3) . @-endorphin levels were elevated during the dark phase, with a peak occurring for all brain parts at 0400 hr.
The diurnal variations in brain P-endorphin concentrations, observed in our studies, could explain the reported diurnal changes in pain threshold and morphine analgesia (Lutsch and Morris, 1972; Frederickson et al., 1977) . These findings lend further support to the hypothesis that the increase in morphine analgesia during the dark phase may be due to a synergistic effect of morphine with the elevated levels of endogenous opioids.
DIURNAL RHYTHM OF ETHANOL-INDUCED HYPOTHERMIA
The ethanol-induced hypothermic action was evaluated in SAFACR male mice (Walker et al., 1983) by determining the recta! temperature 30 min after ethanol administration at C h r intervals throughout the day. Results obtained in this study clearly indicated that ethanol-induced hypothermia varied in a circadian manner ( p c 0.01) after ethanol doses of 3 g/kg, with the greatest effect being observed at lo00 hr and the least effect at O600 hr (Fig. 7) . The diurnal rhythm of ethanol plasma levels 30 min after the injection of 3 g/kg was also evaluated in this study (Walker et al., 1983) . The data show that the peak ethanol plasma levels were obtained at 0200 hr and the trough at loo0 hr (Fig. 8) . The difference between peak and trough plasma ethanol levels was highly signifi- cadian variation in the sensitivity of the brain to ethanol. As previously mentioned, time-dependent alteration in CNS sensitivity to drugs may be the result of fluctuation in the level of brain biogenic amines (Friedman and Walker, 1968, 1969) . Friedman and Walker (1%8) demonstrated a temporal relationship between brain levels of norepinephrine, motor activity, and rectal temperature in rats ( Table 2) . Similar results to the reported circadian rhythm of the brain sensitivity have been shown with pentobarbital (Nelson and Halberg, 1973) and hexobarbital (Holcslaw, 1975) . The sensitivity of the CNS to hexobarbital was greatest in the middle of the light phase, whereas the brain hexobarbital level was higher during the dark phase (Holcslaw, 1975) . Similar conclusions could be drawn from our results on ethanol-induced hypothermia (Walker et al., 1983) . The maximum hypothermic response to ethanol was during the light phase, whereas the highest ethanol plasma level was during the dark phase.
CONCLUSION
Results of various studies conducted in our laboratory strongly suggest that the circadian rhythm of brain neuromodulators may play an important role in the diurnal variation observed in the pharmacologic and/or toxicologic action of CNS drugs. Further investigation on the relationship of neuromodulators and the chronopharmacology and chronotoxicology of CNS drugs is certainly warranted for a better understanding of the mechanisms underlying the rhythmicity of CNS drug responses and for the design of optimal therapeutic regimens with minimal toxicity.
